The Claim
In adults with autoimmune hypothyroidism on levothyroxine therapy, daily selenium supplementation at 200 μg for 12 months reduces thyroid peroxidase antibody levels by approximately 19% compared to placebo, without altering thyroid hormone dosage or the free triiodothyronine–free thyroxine ratio.
What the research says
Supports is higher
Support is ahead, but a single strong opposing study can change this.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
In people with autoimmune hypothyroidism taking levothyroxine, taking 200 micrograms of selenium daily for a year may lower levels of thyroid peroxidase antibodies by about 19% compared to a placebo, but it does not change the required dose of thyroid hormone or the balance between free triiodothyronine and free thyroxine.
See the scientific wording
In adults with autoimmune hypothyroidism on levothyroxine, daily selenium supplementation (200 μg) for 12 months reduces thyroid peroxidase antibody levels by approximately 19% compared to placebo, but this reduction does not translate to changes in thyroid hormone dosage or the free triiodothyronine–free thyroxine ratio.
What the research says
1 studyTaking selenium pills for a year lowered a specific antibody in the blood of people with thyroid disease, just like the claim said—but it didn’t change their medication needs or hormone balance.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.